Phase 1
4
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Monoclonal Antibody
1100%
+ 3 programs with unclassified modality
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AlvotechAdalimumab
PfizerPF-04965842
Astellassolifenacin succinate
AstellasTamsulosin HCl
Clinical Trials (4)
Total enrollment: 350 patients across 4 trials
PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
Start: Jul 2019Est. completion: Dec 2019207 patients
Phase 1Completed
A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers
Start: Jul 2018Est. completion: Oct 201825 patients
Phase 1Completed
A Study to Compare How Much Solifenacin Succinate and Mirabegron Reach the Blood When Administered Together as Fixed-dose Combination Tablets and With Single Individual Tablets of the Same Medications at Three Dose Levels
Start: Sep 2012Est. completion: Nov 201272 patients
Phase 1Completed
EC905 Pharmacokinetic Profile Study
Start: Mar 2009Est. completion: Jul 200946 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space